Showing results 1 to 6 of 6
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Blockade of paracrine supply of follistatin-like 1 (FSTL1) from activated fibroblasts to cancer cells suppresses liver cancer stemness and metastasis Proceeding/Conference:The 25th Research Postgraduate Symposium (RPS), Li Ka Shing Faculty of Medicine, The University of Hong Kong | 2020 | ||
Clinicopathological and prognostic implications of endoglin (CD105) staining in hepatocellular carcinoma and its adjacent liver Proceeding/Conference:Hong Kong-Shanghai International Liver Congress, the 3rd Scientific Meeting of Cheng Si Yuan (China-International) Hepatic Research Foundation, and the 5th Shanghai International Symposium on Liver Cancer and Hepatitis | 2004 | ||
Establishment of human primary hepatocellular carcinoma-derived organoid cultures for disease modeling and drug screening Proceeding/Conference:International Society for Stem Cell Research (ISSCR) Annual Meeting | 2018 | ||
Glucose deprivation induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma Proceeding/Conference:25th Research Postgraduate Symposium (RPS), Li Ka Shing Faculty of Medicine, The University of Hong Kong | 2020 | ||
PRMT6-dependent CRAF/ERK signaling regulates cancer stem cell plasticity in liver cancer Proceeding/Conference:Cancer Research | 2017 | ||
Targeting AXL/PDK1 signaling axis activates immunogenic cell death in liver cancer Proceeding/Conference:AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics | 2021 |